Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 51 publications
Impact of Recent Translational and Therapeutic Developments on Clinical Course of BCR::ABL1-Positive and -Negative Myeloproliferative Neoplasms.
Journal: Hematological oncology
Published: October 01, 2024
Recent Advances in the Biology and CD123-Directed Treatment of Blastic Plasmacytoid Dendritic Cell Neoplasm.
Journal: Clinical lymphoma, myeloma & leukemia
Published: October 30, 2023
Efficacy and manageable safety of tagraxofusp in blastic plasmacytoid dendritic cell neoplasm: a case series of pediatric and adolescent/young adult patients.
Journal: EJHaem
Published: September 29, 2023
Long-Term Benefits of Tagraxofusp for Patients With Blastic Plasmacytoid Dendritic Cell Neoplasm.
Journal: Journal of clinical oncology : official journal of the American Society of Clinical Oncology
Published: July 12, 2022
Perspective: Pivotal translational hematology and therapeutic insights in chronic myeloid hematopoietic stem cell malignancies.
Journal: Hematological oncology
Published: December 28, 2021
Liquid biopsies for residual disease and recurrence.
Journal: Med (New York, N.Y.)
Published: June 02, 2021
Targeting CD123 in hematologic malignancies: identifying suitable patients for targeted therapy.
Journal: Leukemia & lymphoma
Published: May 17, 2021
Expanding the landscape of oncogenic drivers and treatment options in acral and mucosal melanomas by targeted genomic profiling.
Journal: International journal of cancer
Published: December 21, 2020
Precision Medicine in Hematology 2021: Definitions, Tools, Perspectives, and Open Questions.
Journal: HemaSphere
Published: October 27, 2020
Last Updated: 09/26/2026